ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RGT Argent Biopharma Limited

6.00
0.00 (0.00%)
20 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argent Biopharma Limited LSE:RGT London Ordinary Share AU0000326647 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.00 5.00 7.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Director Shareholding

16/07/2003 1:26pm

UK Regulatory


RNS Number:6187N
ReGen Therapeutics PLC
16 July 2003


16 July 2003

ReGen Therapeutics Plc


DIRECTOR'S SHAREHOLDING

London, UK - 16 July, 2003:  ReGen Therapeutics Plc (the "Company") a company
developing a treatment for Alzheimer's Disease has today received notification
from Percy Lomax the Executive Chairman that he has subscribed for 333,333 new
ordinary shares in the placing announced on the 15 July 2003 at 1.5p per new
ordinary share.  This will bring his total holding in the Company to 1,782,069
ordinary shares representing 0.79 per cent of the company's issued share capital
following the placing.



For further information, please contact:

Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033

 

                     This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSEAAXKFASDEFE

1 Year Argent Biopharma Chart

1 Year Argent Biopharma Chart

1 Month Argent Biopharma Chart

1 Month Argent Biopharma Chart